Drugs that contain Chlorpheniramine Polistirex; Codeine Polistirex
1. List of Tuzistra Xr drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8790700 | AYTU | Modified release formulations containing drug-ion exchange resin complexes |
Mar, 2027
(3 years from now) | |
| US8062667 | AYTU | Modified release formulations containing drug-ion exchange resin complexes |
Mar, 2029
(5 years from now) | |
Do you want to check out TUZISTRA XR patents from before 2022?
Market Authorisation Date: 30 April, 2015
Treatment: NA
Dosage: SUSPENSION, EXTENDED RELEASE;ORAL
More Information on Dosage
TUZISTRA XR family patents
25
United States
2
China
2
Denmark
2
Spain
2
European Union
1
Canada
1
Brazil
1
Australia
1
Israel
1
Russia
1
Japan
1
Taiwan
1
Austria
1
Korea, Republic of
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic